67457-630 : Eptifibatide 2 mg/ml Intravenous Injection, Solution


NDC67457-630
Labeler: Mylan Institutional LLC
Product Type: Human Prescription Drug
Drug Name:  Eptifibatide
Dosage Form: Intravenous Injection, Solution
Application #: ANDA203258
Rev. Date: 


NDC Package Codes:

  • 67457-630-10: 1 VIAL IN 1 CARTON (67457‑630‑10) > 100 ML IN 1 VIAL

Active Ingredients:

  • Eptifibatide

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Decreased Platelet Aggregation [PE]
  • Platelet Aggregation Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 67457-629 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 67457-631 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 72078-025 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 72078-026 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 72078-027 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 0338-9558 Eptifibatide 75 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
  • 0338-9559 Eptifibatide 200 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
  • 0703-1165 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-1179 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 14335-070 Eptifibatide 2 mg/ml Intravenous Injection by Hainan Poly Pharm. Co., Ltd.
  • 14335-071 Eptifibatide .75 mg/ml Intravenous Injection by Hainan Poly Pharm. Co., Ltd.
  • 16729-259 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 16729-260 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 17478-902 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Akorn, Inc.
  • 17478-903 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Akorn, Inc.
  • 25021-408 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 25021-409 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 52958-040 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
  • 52958-402 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
  • 55150-218 Eptifibatide 75 mg/100ml Intravenous Injection by Auromedics Pharma LLC
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67457-630 QR Code

< Prev: 67457-629Next: 67457-631 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.